PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,601,378 | -22.2% | 4,622,920 | +23.9% | 0.00% | -25.0% |
Q2 2023 | $49,619,302 | -51.0% | 3,730,775 | -57.3% | 0.00% | -20.0% |
Q1 2023 | $101,166,748 | +8107.7% | 8,736,334 | +5697.8% | 0.01% | – |
Q4 2022 | $1,232,590 | +12.8% | 150,683 | -20.0% | 0.00% | – |
Q3 2022 | $1,093,000 | -79.7% | 188,300 | -84.6% | 0.00% | -100.0% |
Q2 2022 | $5,395,000 | -59.9% | 1,220,723 | -17.5% | 0.00% | 0.0% |
Q1 2022 | $13,463,000 | -63.3% | 1,479,433 | -17.5% | 0.00% | -66.7% |
Q4 2021 | $36,670,000 | +444.8% | 1,792,291 | +580.4% | 0.00% | +200.0% |
Q3 2021 | $6,731,000 | -26.9% | 263,411 | +0.0% | 0.00% | 0.0% |
Q2 2021 | $9,209,000 | -90.7% | 263,338 | -91.2% | 0.00% | -87.5% |
Q1 2021 | $99,136,000 | +1982620.0% | 2,976,162 | +1653323.3% | 0.01% | – |
Q4 2020 | $5,000 | +400.0% | 180 | +252.9% | 0.00% | – |
Q3 2020 | $1,000 | -99.8% | 51 | -99.9% | 0.00% | – |
Q4 2014 | $470,000 | – | 60,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |